Skip to main content

$0.022 0.004 (22.22%)

High

$0.02

Low

$0.02

Trades

1

Turnover

$275

Volume

12,500
30 June 2023 at 3:35pm
Register to track OPL and receive email alerts.

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.

Expand Company Description

Market Cap (10-Oct)

$4,097,160 (2,089th)

Close (30-Jun)

$0.022

Volume (30-Jun)

12,500

Shortsold (11-Oct)

-

52w High

$0.044

52w Low

$0.014

P/E

-

EPS

-0.02
Subject
OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Opyl appoints Dr Hugo Stephenson as Strategic Advisor

OPL Ann: Opyl - Business Update & Appendix 4C

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Change in substantial holding

OPL Ann: Application for quotation of securities - OPL

OPL Ann: Cleansing Notice

OPL Ann: Successful Placement of Shortfall Shares from Rights Issue

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Appendix 4D & Half Year Results

OPL Ann: Change in substantial holding

OPL Ann: Becoming a substantial holder

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Notification of cessation of securities - OPL

OPL Ann: Change of Director's Interest Notice - D Rasheed

OPL Ann: Change of Director's Interest Notice - M Ziirsen

OPL Ann: Application for quotation of securities - OPL

OPL Ann: Results of Rights Issue

OPL Ann: Becoming a substantial holder

OPL Ann: Director Resignation

OPL Ann: Opyl - Business Update & Appendix 4C

OPL Ann: Opyl enters into MSA and new clinical trial recruitment

OPL Ann: Update - Proposed issue of securities - OPL

OPL Ann: Non-Renounceable Rights Issue - Extension of Closing Date

OPL Ann: Becoming a substantial holder

OPL Ann: Notification regarding unquoted securities - OPL

OPL Ann: Application for quotation of securities - OPL

OPL Ann: Minor Timetable Changes

OPL Ann: Reinstatement to Quotation

OPL Ann: Rights Issue Offer Booklet

OPL Ann: Opyl Opens Rights Issue

OPL Ann: Letter to ineligible shareholders

OPL Ann: Cleansing Notice - Rights Issue

OPL Ann: Update - Proposed issue of securities - OPL

OPL Ann: Clarification Statement

OPL Ann: Proposed issue of securities - OPL

OPL Ann: Proposed issue of securities - OPL

OPL Ann: Proposed issue of securities - OPL

OPL Ann: Opyl completes Placement and launches Rights Issue

OPL Ann: Suspension from Official Quotation

OPL Ann: Trading Halt

OPL Ann: Change of Director's Interest Notice x4

OPL Ann: Notification regarding unquoted securities - OPL

OPL Ann: New Constitution

OPL Ann: Results of Meeting

OPL Ann: Chair's Address & AGM Presentation

OPL Ann: Notification of cessation of securities - OPL

Register to track OPL and receive email alerts.

Similar Companies

ALU
BRN
HSN
IRE
ISX
NEA
NXL
OCL
TNE
WTC